Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 413

1.

Salvage Renal Autotransplant Following Previous Renal Vein Stenting in Nutcracker Syndrome.

Al-Qaoud T, Bath N, Redfield R 3rd, Sollinger HW.

Exp Clin Transplant. 2019 May 17. doi: 10.6002/ect.2019.0015. [Epub ahead of print]

2.

Enteric conversion after bladder-drained pancreas transplantation is not associated with worse allograft survival.

Adler JT, Zaborek N, Redfield RR 3rd, Kaufman DB, Odorico JS, Sollinger HW.

Am J Transplant. 2019 Mar 5. doi: 10.1111/ajt.15341. [Epub ahead of print]

PMID:
30838785
3.

The "UW-LPHS Test": A New Test to Predict the Outcome of Renal Autotransplant for Loin Pain Hematuria Syndrome.

Sollinger HW, Al-Qaoud T, Bath N, Redfield RR.

Exp Clin Transplant. 2018 Dec;16(6):651-655. doi: 10.6002/ect.2018.0236. Epub 2018 Sep 25.

4.

Hans W. Sollinger, MD, PhD.

Sollinger HW.

Transplantation. 2018 Sep;102(9):1403-1404. doi: 10.1097/TP.0000000000002236. No abstract available.

PMID:
30124631
5.

Ipsilateral versus contralateral placement of the pancreas allograft in pancreas after kidney transplant recipients.

Yin H, Arpali E, Leverson GE, Sollinger HW, Kaufman DB, Odorico JS.

Clin Transplant. 2018 Aug;32(8):e13337. doi: 10.1111/ctr.13337. Epub 2018 Jul 24.

PMID:
29952108
6.

Impact of ureteral stricture and treatment choice on long-term graft survival in kidney transplantation.

Arpali E, Al-Qaoud T, Martinez E, Redfield RR III, Leverson GE, Kaufman DB, Odorico JS, Sollinger HW.

Am J Transplant. 2018 Aug;18(8):1977-1985. doi: 10.1111/ajt.14696. Epub 2018 Mar 31.

PMID:
29446225
7.

Commentary: Loin Pain Hematuria Syndrome.

Bath NM, Williams DH, Sollinger HW, Redfield RR 3rd.

J Rare Dis Res Treat. 2018;3(4):1-3. doi: 10.29245/2572-9411/2018/4.1169.

8.

An Evaluation of the Safety and Efficacy of Simultaneous Bilateral Nephrectomy and Renal Transplantation for Polycystic Kidney Disease: A 20-Year Experience.

Grodstein EI, Baggett N, Wayne S, Leverson G, D'Alessandro AM, Fernandez LA, Foley DP, Mezrich JD, Odorico JS, Redfield RR 3rd, Sollinger HW, Kaufman DB.

Transplantation. 2017 Nov;101(11):2774-2779. doi: 10.1097/TP.0000000000001779.

PMID:
29064957
9.

Prevalence and outcomes of cystic lesions of the transplant pancreas: The University of Wisconsin Experience.

Al-Qaoud TM, Martinez EJ, Sollinger HW, Kaufman DB, Redfield RR 3rd, Welch B, Leverson G, Odorico JS.

Am J Transplant. 2018 Feb;18(2):467-477. doi: 10.1111/ajt.14540. Epub 2017 Nov 15.

10.

Concurrent biopsies of both grafts in recipients of simultaneous pancreas and kidney demonstrate high rates of discordance for rejection as well as discordance in type of rejection - a retrospective study.

Parajuli S, Arpali E, Astor BC, Djamali A, Aziz F, Redfield RR, Sollinger HW, Kaufman DB, Odorico J, Mandelbrot DA.

Transpl Int. 2018 Jan;31(1):32-37. doi: 10.1111/tri.13007. Epub 2017 Aug 3.

11.

The Importance and Utility of Hemoglobin A1c Levels in the Assessment of Donor Pancreas Allografts.

Arpali E, Scalea JR, Redfield RR 3rd, Berg L, Kaufman DB, Sollinger HW, Welch B, Leverson G, Odorico JS.

Transplantation. 2017 Oct;101(10):2508-2519. doi: 10.1097/TP.0000000000001612.

PMID:
27984519
12.

Only Time Will Tell: The Future of Donation After Circulatory Death.

Scalea JR, Sollinger HW.

Exp Clin Transplant. 2016 Nov;14(Suppl 3):27-31.

PMID:
27805506
13.

Pancreas transplantation in older patients is safe, but patient selection is paramount.

Scalea JR, Redfield RR 3rd, Arpali E, Leverson G, Sollinger HW, Kaufman DB, Odorico JS.

Transpl Int. 2016 Jul;29(7):810-8. doi: 10.1111/tri.12754.

14.

When Do DCD Donors Die?: Outcomes and Implications of DCD at a High-volume, Single-center OPO in the United States.

Scalea JR, Redfield RR, Rizzari MD, Bennett R, Anderson ME, Anderson JE, Kaufman DB, Sollinger HW, Fernandez LA, D'Alessandro AM, Mezrich J.

Ann Surg. 2016 Feb;263(2):211-6. doi: 10.1097/SLA.0000000000001298.

PMID:
26181480
15.

Insulin gene therapy for type 1 diabetes mellitus.

Handorf AM, Sollinger HW, Alam T.

Exp Clin Transplant. 2015 Apr;13 Suppl 1:37-45. Review.

PMID:
25894126
16.

Antithymocyte globulin is associated with a lower incidence of de novo donor-specific antibodies in moderately sensitized renal transplant recipients.

Brokhof MM, Sollinger HW, Hager DR, Muth BL, Pirsch JD, Fernandez LA, Bellingham JM, Mezrich JD, Foley DP, D'Alessandro AM, Odorico JS, Mohamed MA, Vidyasagar V, Ellis TM, Kaufman DB, Djamali A.

Transplantation. 2014 Mar 27;97(6):612-7. doi: 10.1097/TP.0000000000000031. Erratum in: Transplantation. 2016 Sep;100(9):e54.

17.

Acute cellular and antibody-mediated rejection of the pancreas allograft: incidence, risk factors and outcomes.

Niederhaus SV, Leverson GE, Lorentzen DF, Robillard DJ, Sollinger HW, Pirsch JD, Torrealba JR, Odorico JS.

Am J Transplant. 2013 Nov;13(11):2945-55. doi: 10.1111/ajt.12443. Epub 2013 Sep 19.

18.

Differential outcomes of expanded-criteria donor renal allografts according to recipient age.

Mezrich JD, Pirsch JD, Fernandez LA, Foley DP, Bellingham JM, Odorico JS, Leverson GE, Munoz-Del-Rio A, Sollinger HW, Kaufman DB, D'Alessandro AM.

Clin J Am Soc Nephrol. 2012 Jul;7(7):1163-71. doi: 10.2215/CJN.00150112. Epub 2012 May 31.

19.

Alemtuzumab as compared to alternative contemporary induction regimens.

LaMattina JC, Mezrich JD, Hofmann RM, Foley DP, D'Alessandro AM, Sollinger HW, Pirsch JD.

Transpl Int. 2012 May;25(5):518-26. doi: 10.1111/j.1432-2277.2012.01448.x. Epub 2012 Mar 6.

20.

The impact of hepatitis C virus donor and recipient status on long-term kidney transplant outcomes: University of Wisconsin experience.

Singh N, Neidlinger N, Djamali A, Leverson G, Voss B, Sollinger HW, Pirsch JD.

Clin Transplant. 2012 Sep-Oct;26(5):684-93. doi: 10.1111/j.1399-0012.2011.01583.x. Epub 2012 Jan 29.

PMID:
22283142
21.

Pretransplant immune regulation predicts allograft outcome: bidirectional regulation correlates with excellent renal transplant function in living-related donor-recipient pairs.

Jankowska-Gan E, Sheka A, Sollinger HW, Pirsch JD, Hofmann RM, Haynes LD, Armbrust MJ, Mezrich JD, Burlingham WJ.

Transplantation. 2012 Feb 15;93(3):283-90. doi: 10.1097/TP.0b013e31823e46a0.

22.

Simultaneous pancreas and kidney (SPK) retransplantation in prior SPK recipients.

LaMattina JC, Sollinger HW, Becker YT, Mezrich JD, Pirsch JD, Odorico JS.

Clin Transplant. 2012 May-Jun;26(3):495-501. doi: 10.1111/j.1399-0012.2011.01540.x. Epub 2011 Oct 28.

23.

Donation after cardiac death: a 29-year experience.

Bellingham JM, Santhanakrishnan C, Neidlinger N, Wai P, Kim J, Niederhaus S, Leverson GE, Fernandez LA, Foley DP, Mezrich JD, Odorico JS, Love RB, De Oliveira N, Sollinger HW, D'Alessandro AM.

Surgery. 2011 Oct;150(4):692-702. doi: 10.1016/j.surg.2011.07.057.

24.

Luminex-based desensitization protocols: the University of Wisconsin initial experience.

Niederhaus SV, Muth B, Lorentzen DF, Wai P, Pirsch JD, Samaniego-Picota M, Leverson GE, D'alessandro AM, Sollinger HW, Djamali A.

Transplantation. 2011 Jul 15;92(1):12-7. doi: 10.1097/TP.0b013e31821c93bb.

PMID:
21512428
25.

Biliary complications after liver transplantation from donation after cardiac death donors: an analysis of risk factors and long-term outcomes from a single center.

Foley DP, Fernandez LA, Leverson G, Anderson M, Mezrich J, Sollinger HW, D'Alessandro A.

Ann Surg. 2011 Apr;253(4):817-25. doi: 10.1097/SLA.0b013e3182104784.

26.

Pretransplant donor-specific antibodies detected by single-antigen bead flow cytometry are associated with inferior kidney transplant outcomes.

Singh N, Djamali A, Lorentzen D, Pirsch JD, Leverson G, Neidlinger N, Voss B, Torrealba JR, Hofmann RM, Odorico J, Fernandez LA, Sollinger HW, Samaniego M.

Transplantation. 2010 Nov 27;90(10):1079-84. doi: 10.1097/TP.0b013e3181f6a07b.

PMID:
21293194
27.

Long-term outcomes after simultaneous pancreas-kidney transplant.

Wai PY, Sollinger HW.

Curr Opin Organ Transplant. 2011 Feb;16(1):128-34. doi: 10.1097/MOT.0b013e328341b0b5. Review.

PMID:
21150619
28.

Lacto-N-fucopentaose III, a pentasaccharide, prolongs heart transplant survival.

Dutta P, Hullett DA, Roenneburg DA, Torrealba JR, Sollinger HW, Harn DA, Burlingham WJ.

Transplantation. 2010 Nov 27;90(10):1071-8. doi: 10.1097/TP.0b013e3181f8f296.

PMID:
20885339
29.

Outcomes of simultaneous liver/kidney transplants are equivalent to kidney transplant alone: a preliminary report.

Hanish SI, Samaniego M, Mezrich JD, Foley DP, Leverson GE, Lorentzen DF, Sollinger HW, Pirsch JD, D'Alessandro AM, Fernandez LA.

Transplantation. 2010 Jul 15;90(1):52-60.

30.

Is there any role for antithymocyte induction in renal transplantation?

Neidlinger NA, Sollinger HW.

Transplant Proc. 2010 Jun;42(5):1402-7. doi: 10.1016/j.transproceed.2010.04.017.

PMID:
20620444
31.

HLA-A, -B, and -DR zero-mismatched kidneys shipped to the University of Wisconsin, Madison, 1993-2006: superior graft survival despite longer preservation time.

Burlingham WJ, Muñoz del Rio A, Lorentzen D, Sollinger HW, Pirsch JD, Jankowska-Gan E, D'Alessandro A.

Transplantation. 2010 Aug 15;90(3):312-8. doi: 10.1097/TP.0b013e3181e49b9f.

32.

Mycophenolate mofetil versus enteric-coated mycophenolate sodium: a large, single-center comparison of dose adjustments and outcomes in kidney transplant recipients.

Sollinger HW, Sundberg AK, Leverson G, Voss BJ, Pirsch JD.

Transplantation. 2010 Feb 27;89(4):446-51. doi: 10.1097/TP.0b013e3181ca860d.

PMID:
20177347
33.

Folkert O. Belzer and the "hot dog experiment".

Sollinger HW.

Surgery. 2009 Nov;146(5):955-6. doi: 10.1016/j.surg.2009.04.030. Epub 2009 Jul 29. No abstract available.

PMID:
19744451
34.

One thousand simultaneous pancreas-kidney transplants at a single center with 22-year follow-up.

Sollinger HW, Odorico JS, Becker YT, D'Alessandro AM, Pirsch JD.

Ann Surg. 2009 Oct;250(4):618-30. doi: 10.1097/SLA.0b013e3181b76d2b.

PMID:
19730242
35.

FTY720 and everolimus in de novo renal transplant patients at risk for delayed graft function: results of an exploratory one-yr multicenter study.

Tedesco-Silva H, Lorber MI, Foster CE, Sollinger HW, Mendez R, Carvalho DB, Shapiro R, Rajagopalan PR, Mayer H, Slade J, Kahan BD; FTY720A2202 clinical study group.

Clin Transplant. 2009 Sep-Oct;23(5):589-99. doi: 10.1111/j.1399-0012.2009.01070.x. Epub 2009 Aug 27.

PMID:
19719728
36.

Successful reduction of immunosuppression in older renal transplant recipients who exhibit donor-specific regulation.

Jankowska-Gan E, Sollinger HW, Pirsch JD, Cai J, Pascual J, Haynes LD, Munoz del Rio A, Burlingham WJ.

Transplantation. 2009 Aug 27;88(4):533-41. doi: 10.1097/TP.0b013e3181b0f92f.

37.

Early and limited use of tacrolimus to avoid rejection in an alemtuzumab and sirolimus regimen for kidney transplantation: clinical results and immune monitoring.

Knechtle SJ, Pascual J, Bloom DD, Torrealba JR, Jankowska-Gan E, Burlingham WJ, Kwun J, Colvin RB, Seyfert-Margolis V, Bourcier K, Sollinger HW.

Am J Transplant. 2009 May;9(5):1087-98. doi: 10.1111/j.1600-6143.2009.02581.x. Epub 2009 Mar 16.

38.

Stability of alemtuzumab for low-dose induction and test doses.

Vermeulen LC, Puffer EB, Hallam M, Sollinger HW, Hoke R, Kolesar JM.

Am J Transplant. 2009 Mar;9(3):651-2. doi: 10.1111/j.1600-6143.2008.02506.x. Epub 2009 Feb 3. No abstract available.

39.

Alemtuzumab induction and antibody-mediated kidney rejection after simultaneous pancreas-kidney transplantation.

Pascual J, Pirsch JD, Odorico JS, Torrealba JR, Djamali A, Becker YT, Voss B, Leverson GE, Knechtle SJ, Sollinger HW, Samaniego-Picota MD.

Transplantation. 2009 Jan 15;87(1):125-32. doi: 10.1097/TP.0b013e31818c6db0.

PMID:
19136902
40.

Bortezomib as a rescue therapy for hyperacute and multi-drug resistant mixed acute rejection after kidney transplantation.

Djamali A, Muth BL, Torrealba J, Bloom D, Miller KM, Lorentzen D, Sollinger HW, Pirsch JD, Mezrich JD.

Clin Transpl. 2009:485-90. No abstract available.

PMID:
20524320
41.

A comparison of alemtuzumab with basiliximab induction in simultaneous pancreas-kidney transplantation.

Magliocca JF, Odorico JS, Pirsch JD, Becker YT, Knechtle SJ, Leverson GE, Sollinger HW.

Am J Transplant. 2008 Aug;8(8):1702-10. doi: 10.1111/j.1600-6143.2008.02299.x.

42.

Can 'extreme' pancreas donors expand the donor pool?

Neidlinger NA, Odorico JS, Sollinger HW, Fernandez LA.

Curr Opin Organ Transplant. 2008 Feb;13(1):67-71. doi: 10.1097/MOT.0b013e3282f44a51. Review.

PMID:
18660709
43.

The history of the University of Wisconsin transplant program.

Sollinger HW, Becker YT, Burlingham W, D'Alessandro AM, Fernandez LA, Hullett D, Knechtle SJ, Odorico JS, O'Loughlin S, Pirsch JD, Rieselbach RE, Sundberg A, Voss B.

Clin Transpl. 2007:271-87. No abstract available.

PMID:
18637475
44.

Calcineurin inhibitor withdrawal after renal transplantation with alemtuzumab: clinical outcomes and effect on T-regulatory cells.

Pascual J, Bloom D, Torrealba J, Brahmbhatt R, Chang Z, Sollinger HW, Knechtle SJ.

Am J Transplant. 2008 Jul;8(7):1529-36. doi: 10.1111/j.1600-6143.2008.02260.x.

45.

Kidney function after solitary pancreas transplantation.

Odorico JS, Voss B, Munoz Del Rio A, Leverson G, Becker YT, Pirsch JD, Hoffman RM, Sollinger HW.

Transplant Proc. 2008 Mar;40(2):513-5. doi: 10.1016/j.transproceed.2008.01.038.

PMID:
18374117
46.

Antibody-mediated rejection of the kidney after simultaneous pancreas-kidney transplantation.

Pascual J, Samaniego MD, Torrealba JR, Odorico JS, Djamali A, Becker YT, Voss B, Leverson GE, Knechtle SJ, Sollinger HW, Pirsch JD.

J Am Soc Nephrol. 2008 Apr;19(4):812-24. doi: 10.1681/ASN.2007070736. Epub 2008 Jan 30.

47.

Nasogastric decompression is not necessary after simultaneous pancreas-kidney transplantation.

Barth RN, Becker YT, Odorico JS, Sollinger HW.

Ann Surg. 2008 Feb;247(2):350-6. doi: 10.1097/SLA.0b013e3181592870.

PMID:
18216544
48.

New trends in immunosuppression in transplant patients.

Hanaway MJ, Sollinger HW.

Saudi J Kidney Dis Transpl. 2000 Apr-Jun;11(2):137-44. No abstract available.

49.

Developmental exposure to noninherited maternal antigens induces CD4+ T regulatory cells: relevance to mechanism of heart allograft tolerance.

Molitor-Dart ML, Andrassy J, Kwun J, Kayaoglu HA, Roenneburg DA, Haynes LD, Torrealba JR, Bobadilla JL, Sollinger HW, Knechtle SJ, Burlingham WJ.

J Immunol. 2007 Nov 15;179(10):6749-61.

50.

Alemtuzumab induction and recurrence of glomerular disease after kidney transplantation.

Pascual J, Mezrich JD, Djamali A, Leverson G, Chin LT, Torrealba J, Bloom D, Voss B, Becker BN, Knechtle SJ, Sollinger HW, Pirsch JD, Samaniego MD.

Transplantation. 2007 Jun 15;83(11):1429-34.

PMID:
17565315

Supplemental Content

Loading ...
Support Center